United States - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, United States Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 3.9% year on year. With 131 Cases in 2019, the country was ranked number 124 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 131.00 |
| 2018 | 132.00 |
| 2017 | 143.00 |
| 2016 | 113.00 |
| 2015 | 109.00 |
Download all data from 2005 to 2019
How does United States rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 121 |
#121
Cambodia
|
139 | 2019 | +4.5 % | +4.8 % | View data | |
| 124 |
#124
United States
|
131 | 2019 | -0.8 % | +3.9 % | View data | |
| 125 |
#125
Mali
|
130 | 2019 | +5.7 % | +26.6 % | View data | |